What oral ketorolac dose is appropriate for a 4‑year‑old child weighing approximately 16 kg with a toothache?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Ketorolac is Not Approved for Pediatric Patients Under 17 Years of Age

Oral ketorolac should not be prescribed for a 4-year-old child with a toothache, as the FDA explicitly states that oral formulation is not approved for patients under 17 years of age. 1

FDA Labeling and Age Restrictions

  • The FDA drug label clearly indicates that ketorolac tablets are "Oral not approved" for patients under 17 years of age 1
  • The oral formulation is only indicated as continuation therapy following IV or IM dosing in adults, not as initial treatment 1
  • Even in approved adult populations (≥17 years), oral ketorolac requires prior parenteral administration and total treatment duration cannot exceed 5 days 1

Pediatric Use Considerations from Research

While research studies have evaluated ketorolac in pediatric populations, these investigations focused on intravenous administration in postoperative settings, not oral dosing for outpatient dental pain:

  • Intravenous ketorolac at 0.5 mg/kg followed by 1.0 mg/kg every 6 hours (maximum 90 mg/day for 48 hours) has been studied in children for postoperative pain 2
  • These studies specifically excluded infants under 1 year and were conducted in controlled hospital settings with close monitoring 2
  • The pharmacokinetics in children differ significantly from adults, with 2-fold higher volume of distribution and increased clearance requiring higher relative dosing 2

Critical Safety Concerns

A lethal idiosyncratic reaction to ketorolac occurred in one adult with mastocytosis, leading to recommendations to avoid ketorolac entirely in both adults and children with this condition 3. This underscores the serious safety profile of this medication.

  • Ketorolac carries risks of gastrointestinal bleeding, operative site bleeding, and acute renal failure, with risk increasing markedly with high dosages, prolonged use beyond 5 days, and in elderly patients 4
  • The drug has reversible antiplatelet effects that increase bleeding time 2

Recommended Alternatives for Pediatric Dental Pain

For a 4-year-old (approximately 16 kg) with toothache, consider age-appropriate alternatives:

  • Naproxen: 5 to 7.5 mg/kg every 12 hours (80-120 mg every 12 hours for this child), which is supported by the European Society for Paediatric Anaesthesiology for acute pain conditions in children 5
  • Standard pediatric analgesics such as ibuprofen or acetaminophen at weight-based dosing would be more appropriate first-line options

References

Related Questions

Can ketorolac be given as a direct Intravenous (IV) injection?
What is a non-narcotic oral medication similar in strength to Toradol (ketorolac) for pain management?
Is Toradol (ketorolac) potentially addicting, especially in patients with a history of substance abuse or those taking it for an extended period?
After a motor vehicle accident two days ago and an intramuscular Toradol (ketorolac) injection for back pain, what management should I follow and when should I see my primary‑care physician?
Is it safe to take Toradol (ketorolac) at work?
Nine days after a cardiac catheterization, a patient has a right femoral groin hematoma that decreased from 3 cm to 1.5 cm but re‑expanded overnight to a hard, compressible 3 cm mass; ultrasound and contrast‑enhanced computed tomography suggest a tiny pseudoaneurysm. What is the likely pathology and appropriate next step?
Which acute visual disturbances warrant an emergent non‑contrast computed tomography (CT) scan of the head?
What are the likely causes, diagnostic work‑up, and treatment options for dysuria in a married adult male?
For a healthy 12‑month‑old infant at a well‑child visit whose parents decline vaccination today, what factors drive parental vaccine hesitancy, what evidence‑based strategies can improve childhood immunization rates while addressing safety and efficacy concerns, and how should I specifically respond to the claims that vaccines contain toxic ingredients and that children become ill after vaccination?
What is the appropriate dosing and monitoring plan for oral sodium chloride tablets in chronic hyponatremia?
What antipsychotic medication(s) are appropriate for a patient with diabetes who is concerned about weight gain, and what are the recommended dosing guidelines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.